-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recent studies have shown that patients with end-stage renal disease (ESRD) undergoing hemodialysis have a higher risk of gastrointestinal bleeding (GIB) compared with patients without renal disease (NRD)
Recent studies have shown that patients with end-stage renal disease (ESRD) undergoing hemodialysis have a higher risk of gastrointestinal bleeding (GIB) compared with patients without renal disease (NRD)
Patients admitted for GIB (upper and lower) from 2005 to 2013 were extracted from the NIS database using the ICD-9 disease diagnosis
diagnosis
A total of 218,032 patients were included in the study
This study found that ESRD patients with GIB had significantly higher mortality, higher healthcare utilization, but lower rates of endoscopic assessment
This study found that ESRD patients with GIB had significantly higher mortality, higher healthcare utilization, but lower rates of endoscopic assessment
Rajat Garg.
Lower rates of endoscopy and higher mortality in end-stage renal disease patients with gastrointestinal bleeding: A propensity matched national study.
Leave a comment here